Related Experiment Videos

[Cardiac involvement in mucopolysaccharidosis. Apropos of an echocardiographic study in 8 cases]

J Ata1, M Brigui, T Jerad

  • 1Service de Cardiologie, CHU de Sousse.

Annales De Pediatrie
|November 1, 1991
PubMed

Insights

Mucopolysaccharidosis cardiac involvement is often subtle clinically but significant echocardiographically. Valvular dystrophy, particularly on the left side, is the most common finding in these storage diseases.

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Mucopolysaccharidosis (MPS) are rare genetic storage diseases with poorly understood cardiac implications.
  • Cardiac involvement in MPS is often clinically silent, necessitating advanced diagnostic methods.

Purpose of the Study:

  • To investigate the cardiac manifestations of mucopolysaccharidosis using echocardiography.
  • To characterize the prevalence and nature of heart involvement in MPS patients, including Hunter disease.

Main Methods:

  • Echocardiographic assessment of 8 patients with mucopolysaccharidosis.
  • Clinical evaluation alongside detailed echocardiographic analysis of cardiac structures and function.

Main Results:

  • Echocardiography revealed significant cardiac anomalies despite limited clinical symptoms.
  • Valvular dystrophy, predominantly affecting the left heart, was observed in 5 patients.
  • Lesions ranged from asymptomatic to causing stenosis or incompetence; one patient showed septal hypertrophy.

Conclusions:

  • Echocardiography is crucial for detecting cardiac involvement in mucopolysaccharidosis.
  • Valvular disease is the primary cardiac manifestation, impacting heart function.
  • Vascular involvement, including coronary arteries, was not evident in this cohort.

Related Concept Videos